ALEXANDRIA MCCORD: Open Payments
NPI 1255117818 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,049 in 109 payments from 19 companies in 2025. Trend: 2023 $218 · 2024 $2,981 · 2025 $3,049
Food & beverage: $2,666Travel & lodging: $383
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 4 | $782 |
| ABBVIE INC. | 35 | $517 |
| Janssen Biotech, Inc. | 14 | $452 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $279 |
| Janssen Scientific Affairs, LLC | 2 | $188 |
| Gilead Sciences, Inc. | 4 | $177 |
| Regeneron Healthcare Solutions, Inc. | 7 | $171 |
| QOL Medical, LLC | 4 | $110 |
| Phathom Pharmaceuticals, Inc. | 9 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $60 |
Products named: TREMFYA, RINVOQ, ENTYVIO, DUPIXENT, Sucraid, SKYRIZI, VOQUEZNA, LINZESS.
Industry payments across AR — which companies pay providers there.
